Colin Broom M.D., VP & Chief Scientific Officer at VIROPHARMA INC (VPHM), sold 30,000 shares at $13.27 ($398K) on 2010-09-09, disclosed to the SEC on 2010-09-13.
Open-market sale of $398k VPHM by VP & Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.25 | 12,000 | $159K | 40.0% |
| 2 | $13.26 | 100 | $1K | 0.3% |
| 3 | $13.26 | 1,640 | $22K | 5.5% |
| 4 | $13.27 | 2,900 | $38K | 9.7% |
| 5 | $13.28 | 400 | $5K | 1.3% |
| 6 | $13.25 | 6,600 |
| $87K |
| 22.0% |
| 7 | $13.26 | 600 | $8K | 2.0% |
| 8 | $13.26 | 100 | $1K | 0.3% |
| 9 | $13.27 | 200 | $3K | 0.7% |
| 10 | $13.27 | 400 | $5K | 1.3% |
| 11 | $13.25 | 1,300 | $17K | 4.3% |
| 12 | $13.26 | 1,460 | $19K | 4.9% |
| 13 | $13.26 | 100 | $1K | 0.3% |
| 14 | $13.26 | 300 | $4K | 1.0% |
| 15 | $13.27 | 300 | $4K | 1.0% |
| 16 | $13.28 | 300 | $4K | 1.0% |
| 17 | $13.35 | 1,300 | $17K | 4.4% |
| Total | $13.26 avg | 30,000 | $398K | 100% |
| Filing → |
| NBRV | SELL | 2020-08-21 | $7K | — | Filing → |
| NBRV | BUY | 2019-09-03 | $21K | — | Filing → |
| NBRV | BUY | 2018-06-25 | $19K | — | Filing → |